NCT04650854NCT03971422rozanolixizumabgMGgeneralised myasthenia gravisMycarinG
…lixizumab treatment cycle. All patients who enrolled in MG0007 (NCT04650854; open-label extension) received one further treatment cycle wit…
1articles mentioning funders
1funder mentions
1distinct funders extracted
0%of mentions human-reviewed
Active filtersEntity: NCT03971422 ×
NCT03971422
This funder is selected. Its supporting articles are shown below.